ZEEVA THERAPEUTICS CORPORATION — United States · Federal contract register · Supplier record: 1 contracts, all years ($742,100 · Apr 2024 – Apr 2024); $742K since January 2024 (1 contract · 1 agency); 53rd rank in the line (of 102 suppliers · 0.13%); 3 agencies never served ($80.8M on the line without ZEEVA THERAPEUTICS CORPORATION).
Assay record ASY-US-11S42L41TH · Cite as: Assay Systems, “ZEEVA THERAPEUTICS CORPORATION in the USAspending register”, https://assay-systems.com/register/us/zeeva-therapeutics-corporation/
1
contracts, all years
$742,100 · Apr 2024 – Apr 2024
$742K
since January 2024
1 contract · 1 agency
53rd
rank in the line
of 102 suppliers · 0.13%
3
agencies never served
$80.8M on the line without ZEEVA THERAPEUTICS CORPORATION
Own record by year
2024 onward
$742K
202420252026
Who buys from ZEEVA THERAPEUTICS CORPORATION
since January 2024
1agencies
$742Kpaid
100.0%top buyer
Department of Health and Human Services100.0%
$742,100
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
53rdof 102 suppliers
$742,100ZEEVA THERAPEUTICS CORPORATION in the line
0.13%share of the line
0.2%of $485,502,671 spent by Department of Health and Human Services
Agencies that buy the line and never bought from ZEEVA THERAPEUTICS CORPORATION
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.